FASENRA 30 mg/mL

FASENRA 30 mg/mL is a subcutaneous injection solution containing benralizumab, used for managing certain respiratory conditions. This medication is designed to help control symptoms and improve quality of life for eligible patients.

FASENRA 30 mg/mL is primarily used for the maintenance treatment of specific respiratory conditions. It works by targeting and reducing inflammation in the airways, which can help manage symptoms such as shortness of breath and wheezing. Patients often wonder, 'what is FASENRA used for?'—it is typically prescribed for long-term management rather than immediate relief.

Common effects of FASENRA 30 mg/mL may include reactions at the injection site, such as redness or itching. Some users might experience headaches or fatigue. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

FASENRA 30 mg/mL should be stored properly to maintain its effectiveness. It is important to follow the prescribed dosage and administration instructions carefully. Patients with a history of severe allergic reactions to benralizumab or any of its components should avoid using this medication.

FASENRA 30 mg/mL may interact with other medications, including those that suppress the immune system. It is advisable to inform your healthcare provider about all current medications to avoid potential interactions. Alcohol and certain over-the-counter drugs might also affect how this medication works.